| P2093 | author name string | Jin-Ching Lee | |
| | Chin-Kai Tseng | |
| | Chun-Kuang Lin | |
| | Ying-Ting Lin | |
| | Wei-Chun Chen | |
| | Yao-Chin Hsu | |
| | Yu-Hsuan Wu | |
| P2860 | cites work | Epidemiology of hepatitis C virus infection | Q22305500 |
| | Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system | Q27489596 |
| | Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA | Q27489836 |
| | Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection | Q27490296 |
| | [Relationship between cyclooxysenase 2 and serious hepatitis] | Q82798158 |
| | Inhibition of adenovirus infection and adenain by green tea catechins | Q40648467 |
| | Hepatitis C virus RNA replication is regulated by Ras-Erk signalling | Q42992462 |
| | Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2 | Q43001495 |
| | An in vitro coupled transcription/translation reporter system for hepatitis C virus RNA-dependent RNA polymerase | Q43038946 |
| | Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease | Q43039138 |
| | TOP1 and 2, polysaccharides from Taraxacum officinale, attenuate CCl(4)-induced hepatic damage through the modulation of NF-kappaB and its regulatory mediators | Q43156347 |
| | Studies on the effects of tea catechins against hepatitis B virus infection | Q43883203 |
| | Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate | Q44317774 |
| | Cyclooxygenase‐2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression | Q45372711 |
| | Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma | Q45401274 |
| | Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells | Q45723865 |
| | Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study | Q46902097 |
| | Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated mouse macrophages: molecular mechanisms and structure-activity relationship. | Q50696249 |
| | Phase I study of green tea extract in patients with advanced lung cancer. | Q50795596 |
| | Structural biology of hepatitis C virus | Q56762917 |
| | Efficient initiation of HCV RNA replication in cell culture | Q27860520 |
| | Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity | Q28219414 |
| | Antiviral effect of catechins in green tea on influenza virus | Q28270224 |
| | Unravelling hepatitis C virus replication from genome to function | Q29620056 |
| | Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A. | Q30381092 |
| | Advances in the treatment of hepatitis C virus infection | Q30415138 |
| | Docking ligands into flexible and solvated macromolecules. 2. Development and application of fitted 1.5 to the virtual screening of potential HCV polymerase inhibitors | Q33323904 |
| | Steep your genes in health: drink tea. | Q33763749 |
| | The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways | Q33911621 |
| | Natural products as promising drug candidates for the treatment of hepatitis B and C. | Q34015041 |
| | Antiviral strategies in hepatitis C virus infection | Q34251454 |
| | How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors | Q34564784 |
| | Viral hepatitis and liver cancer: the case of hepatitis C. | Q34568619 |
| | Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas | Q34595991 |
| | Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis | Q34597871 |
| | Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins | Q35596979 |
| | Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus | Q35598372 |
| | Treating hepatitis C infection by targeting the host | Q35992555 |
| | Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene | Q36738705 |
| | Modulation of host metabolism as a target of new antivirals | Q36952835 |
| | Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia | Q37517126 |
| | Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects | Q37561259 |
| | Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important? | Q37972767 |
| | (-)-Epigallocatechin gallate inhibits hepatitis C virus (HCV) viral protein NS5B. | Q38331454 |
| | (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus | Q39366534 |
| | (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry | Q39439105 |
| | The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry | Q39491188 |
| | San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. | Q39520749 |
| | Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. | Q39667354 |
| | A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase | Q39716427 |
| | Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560. | Q39793102 |
| | Antiviral effect of epigallocatechin gallate on enterovirus 71. | Q39836361 |
| | Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. | Q39994610 |
| | Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells | Q39998452 |
| | Cell culture and infection system for hepatitis C virus | Q40150021 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| | tea | Q6097 |
| | Hepatitis C virus | Q708693 |
| P304 | page(s) | e54466 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation | |
| P478 | volume | 8 | |